BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 3119980)

  • 1. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 2. Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    JAMA; 1988 Jan; 259(3):345-6. PubMed ID: 3336150
    [No Abstract]   [Full Text] [Related]  

  • 3. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A more potent inactivated polio vaccine.
    Med Lett Drugs Ther; 1988 May; 30(765):50-1. PubMed ID: 3362093
    [No Abstract]   [Full Text] [Related]  

  • 5. Poliomyelitis prevention. Immunization Practices Advisory Committee Centers for Disease Control.
    Ann Intern Med; 1982 May; 96(5):630-4. PubMed ID: 6280539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO policy statement on polio vaccines.
    Wkly Epidemiol Rec; 1995 Dec; 70(49):346-7. PubMed ID: 8652353
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change from oral poliovirus vaccine to inactivated poliovirus vaccine.
    Mele A; Jefferson T; Franco E; Salmaso S
    Lancet; 2002 Oct; 360(9340):1178. PubMed ID: 12387987
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a need for a change in poliomyelitis immunization policy?
    Sabin AB
    Pediatr Infect Dis J; 1987 Oct; 6(10):887-9. PubMed ID: 3696819
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliomyelitis prevention.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 31(3):22-6, 31-4. PubMed ID: 6799765
    [No Abstract]   [Full Text] [Related]  

  • 11. Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis.
    Brown B
    JAMA; 1997 Jan 22-29; 277(4):295. PubMed ID: 9002483
    [No Abstract]   [Full Text] [Related]  

  • 12. Polio vaccines: WHO position paper – March, 2016.
    Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Poliomyelitis: new revelations, renewed polemics and the Hungarian experiences].
    Dömök I
    Orv Hetil; 1983 Jun; 124(23):1355-67. PubMed ID: 6877813
    [No Abstract]   [Full Text] [Related]  

  • 14. Poliovirus vaccine options.
    Zimmerman RK; Spann SJ
    Am Fam Physician; 1999 Jan; 59(1):113-8, 125-6. PubMed ID: 9917578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines.
    Conrad DA; Jenson HB
    Postgrad Med; 1997 Nov; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
    Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
    Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded programme on immunization. Statement on poliomyelitis eradication.
    Wkly Epidemiol Rec; 1995 Dec; 70(49):345-6. PubMed ID: 8652352
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.
    Guérin N; Bregère P; Caudrelier P; Raynaud O
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):815-6. PubMed ID: 9923532
    [No Abstract]   [Full Text] [Related]  

  • 19. Poliomyelitis vaccination--choosing a wise policy.
    Salk J
    Pediatr Infect Dis J; 1987 Oct; 6(10):889-93. PubMed ID: 3696820
    [No Abstract]   [Full Text] [Related]  

  • 20. Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations.
    Salk D
    Rev Infect Dis; 1980; 2(2):258-73. PubMed ID: 6994208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.